FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
- Posted on January 28, 2025
- By CNBC
- 1 Views
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Ozempic's expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.
